The role of estrogen receptor signalling in serous ovarian cancer

被引：0
|
作者：
George, Sophia H. I. [1 ]
Milea, Anca [1 ]
Sowamber, Ramlogan [1 ]
Toccalino, Danielle [1 ]
Shaw, Patricia A. [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4765
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Estrogen receptor expression in ovarian cancer of the hen.
    Trevino, Lindsey S.
    Johnson, Patricia A.
    BIOLOGY OF REPRODUCTION, 2006, : 120 - 120
  • [22] Estrogen receptor subtypes in ovarian cancer - A clinical correlation
    Chan, Karen K. L.
    Wei, Na
    Liu, Stephanie S.
    Xiao-Yun, Liao
    Cheung, Annie N.
    Ngan, Hextan Y. S.
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (01): : 144 - 151
  • [23] HEAR THE ROR! THE ROLE OF WNT SIGNALLING IN OVARIAN CANCER
    Ford, C. E.
    Henry, C. E.
    Llamosas, E.
    Djordjevic, A.
    Hacker, N. F.
    Heinzelmann-Schwarz, V. A.
    Ward, R. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 952 - 952
  • [24] The role of Apela in high-grade serous ovarian cancer
    Daily, Laura R.
    Ganguly, Debolina
    Hayes, D. Neil
    Wang, Yinan
    Sims, Michelle M.
    Cheng, Jinjun
    ElNaggar, Adam C.
    Pfeffer, Lawrence M.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
    Chauhan, Sonali
    Shrivastava, Deepti
    Dhande, Rajasbala
    Deo, Asawari
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [26] Lymphovascular space invasion and estrogen receptor status in high-grade serous ovarian cancer - A multicenter study by the FRANCOGYN group
    Lorenzini, Jerome
    Deberti, Marion
    Body, Gilles
    Carcopino, Xavier
    Touboul, Cyril
    Dabi, Yohann
    Collinet, Pierre
    Coutant, Charles
    Akladios, Cherif
    Lavoue, Vincent
    Bolze, Pierre-Adrien
    Huchon, Cyrille
    Bricou, Alexandre
    Canlorbe, Geoffroy
    Mimoun, Camille
    Bendifallah, Sofiane
    Ouldamer, Lobna
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (01)
  • [27] Aberrant signalling by the Interleukin 6 receptor family in ovarian cancer
    Kumar, J.
    McCullouch, D. R.
    Ward, A. C.
    CYTOKINE, 2012, 59 (03) : 538 - 538
  • [28] Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
    Phyllis van der Ploeg
    Laura A. M. van Lieshout
    Anja van de Stolpe
    Steven L. Bosch
    Marjolein H. F. M. Lentjes-Beer
    Ruud L. M. Bekkers
    Jurgen M. J. Piek
    Cellular Oncology, 2021, 44 : 951 - 957
  • [29] Estrogen-inactivating sulfotransferase has benefical effects in advanced serous ovarian cancer
    Mungenast, F.
    Aust, S.
    Ocko, K.
    Klameth, L.
    Castilo-Tong, Cacsire D.
    Zeillinger, R.
    Van Gorp, T.
    Vergote, I
    Sehouli, J.
    Mahner, S.
    Fogel, M.
    Thalhammer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 266 - 266
  • [30] Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
    van der Ploeg, Phyllis
    van Lieshout, Laura A. M.
    van de Stolpe, Anja
    Bosch, Steven L.
    Lentjes-Beer, Marjolein H. F. M.
    Bekkers, Ruud L. M.
    Piek, Jurgen M. J.
    CELLULAR ONCOLOGY, 2021, 44 (04) : 951 - 957
12345